Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pivotal role of exogenous pyruvate in human natural killer cell metabolism.
Kern Coquillat N, Picq L, Hamond A, Megy P, Benezech S, Drouillard A, Lager-Lachaud N, Cahoreau E, Moreau M, Fallone L, Mathieu AL, Bellvert F, Nizard C, Bulteau AL, Walzer T, Marçais A. Kern Coquillat N, et al. Among authors: drouillard a. Nat Metab. 2025 Jan 3. doi: 10.1038/s42255-024-01188-4. Online ahead of print. Nat Metab. 2025. PMID: 39753710
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study.
Gallois C, Bergen ES, Auclin É, Pernot S, Higué J, Trouilloud I, Touchefeu Y, Turpin A, Mazard T, Sartore-Bianchi A, Prenen H, Alberti A, Pilla L, Cuissy S, Wookey V, Perret A, Melchior C, Artru P, Dubreuil O, Drouillard A, Doat S, Lavolé J, Basile D, Perkins G, Jary M, Stintzing S, Ros J, Tougeron D, Taieb J. Gallois C, et al. Among authors: drouillard a. ESMO Open. 2024 Sep;9(9):103696. doi: 10.1016/j.esmoop.2024.103696. Epub 2024 Sep 9. ESMO Open. 2024. PMID: 39255538 Free PMC article.
Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints.
Pouxvielh K, Marotel M, Drouillard A, Villard M, Moreews M, Bossan A, Poiget M, Khoryati L, Benezech S, Fallone L, Hamada S, Rousseaux N, Picq L, Rocca Y, Berton A, Teixeira M, Mathieu AL, Ainouze M, Hasan U, Fournier A, Thaunat O, Marçais A, Walzer T. Pouxvielh K, et al. Among authors: drouillard a. Sci Adv. 2024 Aug 30;10(35):eadn0164. doi: 10.1126/sciadv.adn0164. Epub 2024 Aug 28. Sci Adv. 2024. PMID: 39196934 Free PMC article.
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study.
Varnier R, Toullec C, Philonenko S, Dupré A, Artru P, Hafliger E, Drouillard A, Torregrosa C, Pernot S, McLellan P, Lecomte T, Moulin V, Lécaille C, Touchefeu Y, Locher C, Taieb J, Coutzac C. Varnier R, et al. Among authors: drouillard a. Dig Liver Dis. 2024 Sep;56(9):1605-1613. doi: 10.1016/j.dld.2024.02.009. Epub 2024 Feb 24. Dig Liver Dis. 2024. PMID: 38403514
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Piquemal D, Bruno R, Bournet B, Ghiringhelli F, Noguier F, Canivet C, Bertaut A, Pierrat F, Evesque L, Gamez A, Cros J, Rederstorff E, Petit E, Adnet J, Saint A, Drouillard A, Kempf E, Soularue E, Vincent J, Baumgaertner I, Hennequin A, Tournigand C, Lopez Trabada Ataz D, Bengrine L, Lepage C, Manfredi S, Afchain P, Trouilloud I, Gagnaire A, LoConte NK, Bachet JB. Piquemal D, et al. Among authors: drouillard a. J Gastrointest Oncol. 2023 Apr 29;14(2):997-1007. doi: 10.21037/jgo-22-946. Epub 2023 Apr 10. J Gastrointest Oncol. 2023. PMID: 37201091 Free PMC article.
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice.
Moreews M, Mathieu AL, Pouxvielh K, Reuschlé Q, Drouillard A, Dessay P, Meignien M, Zhang J, Fallone L, Rousseaux N, Ainouze M, Rey A, Omarjee O, Decembre E, Lenief V, Djebali S, Thaunat O, Dreux M, Genestier L, Defrance T, Soulas-Sprauel P, Marçais A, Walzer T, Belot A. Moreews M, et al. Among authors: drouillard a. J Immunol. 2023 May 1;210(9):1209-1221. doi: 10.4049/jimmunol.2200818. J Immunol. 2023. PMID: 36961448
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Bergen ES, Pilla L, Auclin E, Ilhan-Mutlu A, Prager GW, Pietrantonio F, Antista M, Ghelardi F, Basile D, Aprile G, Longarini R, Hautefeuille V, Tougeron D, Artru P, Mabro M, Drouillard A, Roth G, Ben Abdelghani M, Clement I, Toullec C, Mineur L, Guimbaud R, Taieb J, Zaanan A. Bergen ES, et al. Among authors: drouillard a. Gastric Cancer. 2023 May;26(3):425-437. doi: 10.1007/s10120-023-01374-5. Epub 2023 Mar 7. Gastric Cancer. 2023. PMID: 36881202
Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring.
Legris P, Bouillet B, Pâris J, Pistre P, Devaux M, Bost S, Simoneau I, Manfredi S, Drouillard A, Bastie JN, Chaix M, Massoud P, Rouland A, Aho S, Boulin M, Petit JM. Legris P, et al. Among authors: drouillard a. Acta Diabetol. 2023 Apr;60(4):545-552. doi: 10.1007/s00592-023-02032-z. Epub 2023 Jan 13. Acta Diabetol. 2023. PMID: 36637528
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
Auvray Kuentz M, Hautefeuille V, de Mestier L, Coutzac C, Lecomte T, Nardon V, Artru P, Turpin A, Drouillard A, Malka D, Tran-Minh ML, Trouilloud I, Lièvre A, Williet N, Pernot S, Touchefeu Y, Taieb J, Hammel P, Zaanan A. Auvray Kuentz M, et al. Among authors: drouillard a. Int J Cancer. 2023 May 1;152(9):1894-1902. doi: 10.1002/ijc.34414. Epub 2023 Jan 3. Int J Cancer. 2023. PMID: 36562310 Free article.
40 results